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Abstract
Background: Most focal nodular hyperplasia (FNH) cases are diagnosed by chance. We studied a
case of pre-FNH. We used glutamine synthase as an immunohistochemical marker for perivenous
zones.
Results: Neither fibrotic scars nor hepatocytic nodules surrounded by fibrosis with a ductular
reaction were observed in the sections studied. Most sections generally displayed preserved
architecture. The glutamine synthase-positive hepatocyte areas were wider than those observed in
non-tumoural surrounding liver, and they tended to extend outwards. Portal tracts bordering the
nodule were more fibrotic, with an absence of portal veins and ducts and with arterial proliferation
often in proximity with large draining veins; isolated arteries were present and hepatic veins were
rare in the nodule. These features appeared prior to the identification of other major criteria
characteristics of FNH, thus supporting the "hypothesis of Wanless".
Conclusion: The findings confirm that in FNH there is a portal tract injury leading to local portal
vein injury. This leads to a cascade of events, including arterial venous shunts, ductular reaction,
and scar formation.
Background
The estimated prevalence of focal nodular hyperpla-
sia(FNH) is 0.4 to 3% in a non-selected autopsy series and
0.3% in a clinical series. Most FNH cases are diagnosed by
chance, but some are symptomatic. In contrast to hepato-
cellular adenomas, imaging techniques are sufficient for
diagnosis in 70% of FNH cases. Histopathological exami-
nation is required for diagnosis in the few cases that have
non-diagnostic imaging features [1,2]. In about two-
thirds of cases, the FNH lesion is solitary. The typical his-
topathological features of classic FNH include a firm,
well-delimited but not encapsulated lesion composed of
hepatocellular nodules, a central scar, and radiating
fibrous cords. The fibrous regions typically contain large
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dystrophic arteries and ductular reaction, usually associ-
ated with a lymphocytic infiltrate. FNH can be diagnosed
from a liver biopsy. However, in some cases of FNH, the
histopathological diagnosis may still be difficult, even in
a resected specimen; this is because the definitive his-
topathological features may be absent, inconspicuous, or
atypical. FNH can be associated with vascular abnormali-
ties, including hepatic hemangiomas, which support vas-
cular involvement in the pathogenesis of this lesion [3,4].
FNH has also been reported in patients with a variety of
non-hepatic tumours and tumour-like conditions [4].
Recently, Wanless et al. hypothesized that the primary
lesion of FNH is the result of a portal tract injury leading
to injury of the local portal vein (PV) with secondary large
arterial-PV shunts [5]. We studied the early stages of FNH
formation to help validate this hypothesis. Thus, we
reviewed a pre-FNH case previously published [6], taking
advantage of glutamine synthase (GS) staining; this stain-
ing technique recognises hepatic veins surrounded by GS-
positive hepatocytes or the distal part of zone 3 if the cen-
tral vein is not visible [7].
Case presentation
A white female patient born in 1950 was reported to have
vesicular polyps for several years. In 2000, she presented
with biliary colic, and a stone was detected in her gallblad-
der. A hypoechoic nodule was also identified in the left
lobe (Fig. 1). Isointense patterns relative to liver paren-
chyma on T1-weighted and T2-weighted images with
strong enhancement at arterial phase, and no wash-out at
portal venous phase favoured a benign liver nodule. How-
ever, the diagnosis of FNH could not be achieved with cer-
tainty, due to the absence of all the imaging criteria and,
above all, the absence of a central scar. The diagnosis of
adenoma could not be excluded even if homogeneous
and isointense patterns on both T1 and T2 weighted
images are considered rare for this kind of lesion. Further-
more, there was no evidence of fat deposits within this
lesion (Fig. 1). The patient had been taking oral contra-
ceptives for 10 years. Liver function tests for the patient
were normal. A left hepatectomy and a cholecystectomy
were performed at the same time. The resected nodule was
barely visible on an examination of gross anatomy, and
was slightly clearer than the surrounding liver paren-
chyma (Fig. 2). This nodule was the base of this study.
We sampled three representative sections of the nodule
whole surface and non-tumoural surrounding tissue. The
following stains and immunostains were performed on
serial sections from 2 blocks: H&E, Masson's trichrome,
cytokeratines (CK) 7 and 19, α-smooth muscle actin
(SMA), and GS. Additional immunostaining included
CD34 for characterising capillarised sinusoids, CRBP1
(cellular retinol binding protein-1) for hepatic stellate
cells, CD3 and CD20 for T- and B-lymphocytes, respec-
tively, and CD68 for histiocytes.
The non-tumoural liver was steatotic (30%), and the nod-
ule was less steatotic in comparison. Early stage FNH for-
mation was diagnosed due to frank ductular reaction,
observed around the arteries in two small areas (see Fig. 3,
[6]). We observed no fibrotic scars, or hepatocytic nodules
surrounded by fibrosis with ductular reaction in the sec-
tions studied.
Most sections generally displayed preserved architecture
(Fig. 3, 4, 5, 6, 7 and 8). Distinctions between nodular and
non-nodular tissues were made using GS immunostain-
ing (Fig. 3, 4). Inside the nodule, GS-positive hepatocyte
areas were wider around central veins if visible (Fig. 9),
and tended to extend outwards (Fig. 3, 4, 7, 10). Surpris-
ingly, hepatic veins (HV) in some GS-positive areas were
missing or had undergone fibrosis (Fig. 10, 11). GS stain-
ing was sometimes also present around thin vessels,
resembling dilated sinusoids (Fig. 12). Also in some GS-
positive areas, only arteries were visible (Fig. 13, 14). GS
staining was sometimes also present around thin vessels,
resembling dilated sinusoids (Fig. 12). However, isolated
arteries either along septa or in the parenchyma, often in
close proximity (Fig. 15, 16) or in contact with large drain-
ing vessels, were visible (Fig. 17). At the nodule periphery,
portal tracts were slightly fibrous, containing thicker arter-
ies and remnants of PV, and fewer ducts and ductules (Fig.
18, 19). No true portal tracts, and no bile ducts or ductules
were observed in the nodule (Fig. 20).
The nodule had fewer hepatic stellate cells than those
observed in non-tumour parenchyma, (Fig. 21); these
stellate cells were not activated (Fig. 15, 16, 17 and 18),
i.e., they were α-SMA negative. There was no major differ-
ence regarding capillarisation of sinusoids in periportal
and septal areas, between the tumoral liver and the non-
tumoral (Fig. 22). Portal tracts of the nodule also had
fewer macrophages (Fig. 23) and more B and T lym-
phocytes (Fig. 24, 25) than those of non-tumour paren-
chyma.
Discussion
FNH is frequently observed in tertiary referral centres. The
diagnosis is usually easy using imaging techniques, such
as ultrasound contrast agents, or MRI. If imaging tech-
niques or biopsies cannot exclude adenoma [1], a diagno-
sis can also be made using the resected specimen. We
found the use of various immunohistochemical methods,
including LFABP (cellular retinol binding protein), β-cat-
enin, SAA (serum amyloid A) and GS [8], very useful for
differentiating between FHN and adenoma in difficult
cases.Comparative Hepatology 2008, 7:2 http://www.comparative-hepatology.com/content/7/1/2
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Contrast-enhanced T1-weighted images Figure 1
Contrast-enhanced T1-weighted images. They show strong enhancement of the lesion (white arrow) at arterial phase 
(A) and isointense signals relative to liver parenchyma at portal venous phase (B).
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Glutamine synthase, physiologically expressed in one or
two hepatocyte plates located immediately beside the cen-
tral veins in normal liver, is over-expressed in FNH with
over-stained hepatocytes generally forming large areas;
often anastomosed in a "map-like" pattern occasionally
centred by central veins, whereas GS positive areas remain
distant from fibrous bands. This zonal pattern of GS
expression in FNH strongly differs from the homogeneous
staining usually observed in adenomas and adenomas in
which β-catenin is mutated [8].
Surprisingly, there is not much data in relation to FNH
formation [6]. In this case, the lobular structure was gen-
erally preserved in each of the sections studied, and we
observed no ductular reaction and no fibrosis. Hepatic
veins were identified from portal tracts with certainty, as a
result of GS localization, and isolated arteries were visu-
ally detected well with α-SMA, thus providing a better
understanding of FNH.
From this study, it is clear that in early stages of FNH for-
mation there are various features: a) at the border, there
were abnormal portal tracts, which were more fibrotic,
and there was also an absence of portal veins and ducts
and arterial proliferation, often in proximity with large
draining veins; b) isolated arteries in the lesion; c) an
absence or rarefaction of hepatic veins. All these features
appeared prior the identification of other major character-
istics of FNH, i.e., nodules circled by fibrous bands, duc-
tular reaction, abnormal vessels and several arteries in
fibrotic bands.
These observations support suggestions by Wanless et al.
[5] and confirm that in FNH there is a portal tract injury
leading to local PV injury. Wanless' group has suggested
that the PV injury (from thrombosis or phlebitis) leads to
a cascade of events, such as secondary large arterio-PV
shunts. Arterio-PV shunts lead to the arterialisation of PV
with irregular intimal thickening resembling a dystrophic
Macroscopic view (A, B) of the nodule (formalin fixed tissue) Figure 2
Macroscopic view (A, B) of the nodule (formalin fixed tissue). Then nodule appears slightly clearer than the surround-
ing liver parenchyma (dotted line).Comparative Hepatology 2008, 7:2 http://www.comparative-hepatology.com/content/7/1/2
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Two sections (A, B) of the nodule Figure 3
Two sections (A, B) of the nodule. The GS staining allows the distinction between non-nodular tissue and the nodule. The 
broken line delineates the frontier. Figures 9, 20–25 are from section A. The upper figure is from non-nodular tissue and the 
lower figure is from the nodular area. Figures 4-6 are from section B (blue rectangle). Figures 7, 8, 10-19 are from the same 
section (yellow rectangle). The upper and lower microphotographs illustrate the same area (serial sections).
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Junction between non-nodular tissue (lower part) and nodule (upper part) Figure 4
Junction between non-nodular tissue (lower part) and nodule (upper part). The upper micrograph (A) displays GS 
staining, and the lower micrograph (B) shows H&E staining. The GS stained area is wider in the nodular part than in the non-
nodular part. The lobular structure of the liver is not easily visible in the nodular part.
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Junction between non-nodular tissue (lower part) and nodule (upper part) Figure 5
Junction between non-nodular tissue (lower part) and nodule (upper part). The upper micrograph (A) shows α-SMA 
staining, and the lower micrograph (B) exhibits trichrome staining. At the junction between the nodular and non-nodular part, 
portal tracts are more fibrotic (trichrome). The nodular parts contain many isolated arteries.
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Junction between non-nodular tissue (lower part) and nodule (upper part) Figure 6
Junction between non-nodular tissue (lower part) and nodule (upper part). The upper micrograph (A) shows CK7 
staining, and the lower micrograph (B) displays CK19 staining. There is no (CK19) or less (CK7) biliary cells in the nodular part 
compared to the non-nodular part.
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Another area of the previously described upper section Figure 7
Another area of the previously described upper section. The figure shows the upper section as previously described 
(Fig. 4-5), but in another area. The upper micrograph (A) shows GS staining, and the lower micrograph (B) has CK7 staining. It 
confirms the extension of GS staining and the decrease number of biliary cells in the nodule.
GS
CK7
100 μ μ μ μm
100 μ μ μ μm
A
BComparative Hepatology 2008, 7:2 http://www.comparative-hepatology.com/content/7/1/2
Page 10 of 28
(page number not for citation purposes)
Another area of the previously described upper section Figure 8
Another area of the previously described upper section. The figure shows the upper section as previously described 
(Fig. 4-5), but in another area. The upper micrograph (A) was trichrome stained, and the lower micrograph (B) was α-SMA 
stained. It confirms the proliferation of arteries in the nodules and the presence of fibrotic portal tracts at the periphery of the 
nodule.
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Glutamine synthase immunostaining Figure 9
Glutamine synthase immunostaining. A: Normal expression of GS around the central vein (non-nodular tissue). B: 
Extended staining around hepatic veins in the nodule.
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Typical GS staining in the nodule Figure 10
Typical GS staining in the nodule. A – Higher magnification. B – Lower magnification. The nodule partly surrounds arterial 
vessels – these were better seen using α-SMA staining. The blue arrow indicates an artery, whereas the black arrow indicates 
a small hepatic vein (insert) with a thick wall and a narrow almost absent lumen.
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Small hepatic veins Figure 11
Small hepatic veins. A – GS staining. B – α-SMA staining. In the rather faint GS-positive area, a small hepatic vein (black 
arrow) was identified on the right. The vascular lumen was no longer observed on the left (blue arrow). No artery was seen in 
the vicinity.
GS
α α α α− − − −SMA
10 μ μ μ μm
10 μ μ μ μm
A
BComparative Hepatology 2008, 7:2 http://www.comparative-hepatology.com/content/7/1/2
Page 14 of 28
(page number not for citation purposes)
GS-positive hepatocytes Figure 12
GS-positive hepatocytes. A – GS staining. B – H&E staining. A clump of GS-positive hepatocytes (see boxes on Fig. 8) was 
observed around dilated sinusoids. Hepatic veins were not visible in this area.
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GS-positive staining Figure 13
GS-positive staining. A – Lower magnification. B – Higher magnification The GS staining surrounds unstained hepatocytes 
(asterisk). Hepatic veins were not visible; a small artery (arrow) was seen at the edge of the GS-positive area.
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GS positive foci Figure 14
GS positive foci. GS foci (A – upper panel) contained a small artery (black arrow and insert) very close to arterial branches 
(blue arrows), better seen in a α-SMA staining (B – lower panel).
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GS and α-SMA staining Figure 15
GS and α-SMA staining. A closer view (see Fig. 8, box on the left): upper micrograph (A) shows GS staining, and lower 
micrograph (B) shows α-SMA staining. Arteries (α-SMA staining) are close to large hepatic veins (GS staining).
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GS and α SMA staining Figure 16
GS and α SMA staining. A closer view (see Fig. 8 box in the middle): upper micrograph (A) has GS staining, and lower 
micrograph (B) displays α-SMA staining. It illustrates another example of the close vicinity between arteries (α-SMA staining) 
and hepatic veins (GS staining).
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Arterial vessels Figure 17
Arterial vessels. A – GS staining. B – α-SMA. Arterial vessels (arrow, insert) were in close contact with the large hepatic vein 
partly surrounded by GS-positive hepatocytes.
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Fibrotic portal tract Figure 18
Fibrotic portal tract. A fibrotic portal tract (see Fig. 6, box on the left) is observed at higher magnification. There are several 
arteries and a few ducts and ductules (A – α-SMA staining). A possible portal vein remnant can also be identified (B – tri-
chrome staining) (arrow).
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Fibrotic portal tract Figure 19
Fibrotic portal tract. A fibrotic portal tract (see Fig. 6, box on the right) is observed at higher magnification. The wall of the 
portal vein appears damaged (A – trichrome staining). Remnants of small bile ducts can also be identified (B – CK7 staining), 
and an aberrant vessel is at the top of the figure.
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Non-tumoral liver and nodule Figure 20
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. Ducts and ductules (CK7 and CK19) were more dif-
ficult to identify and less numerous in the tumoral liver than in the non-tumoral liver.
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Non-tumoral liver and nodule Figure 21
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. Hepatic stellate cells identified by CRBP-1 are less 
visible in the tumoral liver than in the non-tumoral liver.
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Non-tumoral liver and nodule Figure 22
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. There is no major difference regarding capillarisation 
of sinusoids in periportal and septal areas between the tumoral liver and the non-tumoral liver.
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Non-tumoral liver and nodule Figure 23
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. There are less macrophages (CD68) in the tumoral 
liver than in the non-tumoral liver.
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Non-tumoral liver and nodule Figure 24
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. There are more CD3 lymphocytes in the tumoral 
liver than in the non-tumoral liver.
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Non-tumoral liver and nodule Figure 25
Non-tumoral liver and nodule. A – non-tumoral liver, and B – nodule. There are more CD20 lymphocytes in the tumoral 
liver than in the non-tumoral liver.
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artery. Wanless and colleagues have also suggested that
duct loss is related to portal tract changes, and that the
entry of enlarged arteries in the hepatic venous bed could
be the consequence of congestive injury.
It is not possible to fully understand the pathogenesis of
FNH from a single case. It is possible, however, from our
current understanding of the role of the hepatic artery in
the normal liver [9] to propose a direct role of this vessel
in FNH formation.
In normal livers, the artery within the portal tract supplies
three compartments: the peribiliary vascular plexus, the
portal tract interstitium, and the portal vein wall. How-
ever, the artery outside the portal tract (termed isolated
artery) supplies two compartments: the hepatic capsule
and the hepatic vein wall [9].
The prime cause of FNH may be arterial, due to the lack of
branches to various tributaries (portal, hepatic veins and
ducts). This lack of branches may lead to conditions that
are either primary (malformative focal arterial disease) or
secondary to inflammation (as suggested by an increased
number of inflammatory cells in portal tracts); this in turn
leads to the disappearance of portal vein, bile ducts, and
hepatic veins, subsequently resulting in the enlargement
and proliferation of arteries, in venous shunts (portal and
hepatic) and in all other features described by Wanless et
al. [5]. Disappearance of bile ducts may lead to cholesta-
sis, and therefore to ductular reaction and fibrosis.
The aim of this study was not to confirm the presence of
arterio-venous shunts (portal vein or hepatic vein). The
existence of these shunts proposed by Wanless' group is
however very likely (proximity of artery to hepatic vein,
and dystrophic arterial vessels in portal tracts).
The suggestion of an arterial malformation is consistent
with the possibility of discovering FNH during foetal life
and in infancy, the stability of the lesions over time, the
association with other vascular malformations, and the
singular or multiple nature of nodules [1].
Conclusion
Our observations confirm that in FNH there is a portal
tract injury defined by the disappearance of portal vein,
bile ducts, and hepatic veins, subsequently leading to the
enlargement and proliferation of arteries, and to venous
shunts (portal and hepatic). The prime cause of FNH may
be arterial.
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